IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CIRELLO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.244
AS - Asia 3.708
NA - Nord America 3.665
SA - Sud America 333
AF - Africa 91
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.530
GB - Regno Unito 1.355
SG - Singapore 1.115
CN - Cina 1.112
IT - Italia 938
DE - Germania 552
HK - Hong Kong 335
BD - Bangladesh 332
SE - Svezia 297
RU - Federazione Russa 287
VN - Vietnam 278
BR - Brasile 249
NL - Olanda 190
IN - India 168
FR - Francia 153
UA - Ucraina 102
CA - Canada 91
TR - Turchia 84
IE - Irlanda 82
FI - Finlandia 80
KR - Corea 78
JP - Giappone 48
CI - Costa d'Avorio 44
EU - Europa 43
ID - Indonesia 43
DK - Danimarca 41
BE - Belgio 31
CO - Colombia 30
AR - Argentina 22
ES - Italia 20
IQ - Iraq 17
PL - Polonia 17
EC - Ecuador 14
MX - Messico 14
UZ - Uzbekistan 14
AT - Austria 13
AU - Australia 13
EG - Egitto 13
GR - Grecia 12
RO - Romania 11
SK - Slovacchia (Repubblica Slovacca) 10
CH - Svizzera 9
JO - Giordania 8
ZA - Sudafrica 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
LV - Lettonia 7
TH - Thailandia 7
HR - Croazia 6
IR - Iran 6
JM - Giamaica 6
KE - Kenya 6
LB - Libano 6
PH - Filippine 6
PK - Pakistan 6
TW - Taiwan 6
VE - Venezuela 6
MA - Marocco 5
PT - Portogallo 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
KZ - Kazakistan 4
NP - Nepal 4
PY - Paraguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CL - Cile 3
HN - Honduras 3
LT - Lituania 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BH - Bahrain 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 12.093
Salva come PNG Salva come JPEG
Città #
Southend 1.225
Singapore 656
Ashburn 431
Milan 324
Chandler 318
Hong Kong 308
San Jose 243
Beijing 212
Dallas 167
Frankfurt am Main 157
Seattle 147
Council Bluffs 123
Wilmington 106
Princeton 103
Los Angeles 100
New York 97
Ho Chi Minh City 93
Ann Arbor 92
Hefei 86
Jacksonville 85
Santa Clara 82
Dublin 81
Bengaluru 74
Hanoi 71
Boardman 63
Fairfield 62
Buffalo 59
Lauterbourg 59
Dearborn 57
Toronto 56
Nanjing 55
Woodbridge 49
Mountain View 48
Guangzhou 47
Shanghai 47
Abidjan 44
Somerville 42
Des Moines 41
Moscow 41
Redmond 39
Houston 36
Tokyo 35
The Dalles 34
Kent 31
Rome 31
Cambridge 30
Columbus 29
Redwood City 29
Serra 29
Bühl 28
Sakarya 28
Bogotá 27
Jakarta 27
Jinan 27
Munich 27
São Paulo 27
Helsinki 26
Andover 24
Nanchang 24
Cangzhou 23
Naples 23
Chicago 22
Hebei 21
Brussels 20
Florence 20
Shenyang 20
Changsha 19
Da Nang 19
Kiez 19
Phoenix 19
Bologna 17
Seoul 17
Tianjin 17
Turin 16
Atlanta 15
Zhengzhou 15
Düsseldorf 13
Nuremberg 13
Palermo 13
Berlin 12
Haiphong 12
Ottawa 12
Fuzhou 11
Istanbul 11
Rio de Janeiro 11
San Diego 11
Verona 11
Athens 10
Besnate 10
Falls Church 10
Hangzhou 10
Mumbai 10
Stockholm 10
Eitensheim 9
Lecco 9
London 9
Bernolákovo 8
Biên Hòa 8
Grafing 8
Hanover 8
Totale 7.310
Salva come PNG Salva come JPEG
Nome #
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability 671
Clinical and molecular analyses of thyroid cancer in patients treated for benign diseases 338
Segmental Maternal UPD of Chromosome 7q in a Patient With Pendred and Silver Russell Syndromes-Like Features 309
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives 301
High phenotypic intrafamilial variability in patients with Pendred syndrome and a novel duplication in the SLC26A4 gene: clinical characterization and functional studies of the mutated SLC26A4 protein 274
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature 267
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors 266
Fetal cell microchimerism in papillary thyroid cancer : a possibile role in tumor demage and tissue repair 261
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour : report of three cases with molecular analysis and review of the literature 250
Absence of BRAF mutations in endocrine tumors 248
Total iodide organification defect : clinical and molecular characterization of an Italian family 246
Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report 244
Telomerase in differentiated thyroid cancer : promoter mutations, expression and localization 243
Fetal cell microchimerism in papillary thyroid cancer 230
Allelic distribution of six RET polymorphisms in sporadic medullary thyroid cancer and functional analysis of G691S variant 227
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer 224
Fetal cell microchimerism in papillary thyroid cancer : studies in peripheral blood and tissues 220
Fetal cell microchimerism in papillary thyroid cancer : a role in the outcome of the disease 220
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation : clinical and molecular studies 218
Molecular and functional studies of 4 candidate loci in Pendred syndrome and nonsyndromic hearing loss 216
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers 214
Fetal cell microchimerism in papillary thyroid cancer : a possible role in tumour demage and tissue repair 211
Tumor and normal thyroid spheroids : from tissues to zebrafish 211
Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer? 210
BRAF mutations in an Italian series of thyroid cancers 209
Gitelman’s sindrome : description of a new case in a family with RTH 208
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome 208
Correlation between B-RAF(V600E) mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature 207
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases 207
Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer. 205
RET genotypes comprising specific haplotypes of polymorphic variants are associated with sporadic medullary thyroid cancer 201
FAM83B is involved in thyroid cancer cell differentiation and migration 192
RET genotypes in sporadic medullary thyroid cancer : studies in a large Italian series 192
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer 191
The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects 191
Analysis of a deiodinase 2 polymorphism (oRFa-Asp) in patients with Graves’ disease and controls : preliminary results 189
Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer 187
Molecular analysis in three cases of medullary and papillary thyroid carcinoma occurring as collision tumors 179
The role of Ret genotypes as modifier loci for sporadic medullary cancer 175
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia : reactive or neoplastic C-cell hyperplasia? 173
Tissue sensitivity to thyroid hormones may change over time 167
Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance 160
Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families 160
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies 157
Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al 152
Fetal cell microchimerism and susceptibility to COVID-19 disease in women 150
Fetal microchimerism in women with thyroid cancer 148
Fetal cell microchimerism in women with thyroid cancer 146
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2) : insights from a large series of familial non-medullary thyroid cancers and literature review 144
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer 143
Fetal microchimerism as an explanation of disease 142
Pendred’s sindrome : from genotype to phenotype 141
Role of glucocorticoid receptor polymorphism in adrenal incidentalomas 133
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants 126
Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors 122
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer 122
Evidence of a low prevalence of ras mutations in a large medullary thyroid cancer series 120
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies 107
Fetal cell microchimerism in human cancers 101
Novel insights into the link between fetal cell microchimerism and maternal cancers 101
Modifications in the papillary thyroid cancer gene profile over the last 15 years 97
Microchimerism and endocrine disorders 86
Positive effect of fetal cell microchimerism on tumor presentation and outcome in papillary thyroid cancer 83
Cancer 80
The therapeutic outcome of intravenous steroid therapy for active Graves{'} orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor 49
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors 25
Diabetes mellitus in a girl with thyroid hormone resistance syndrome: A little recognized interaction between the two diseases 7
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function 5
Totale 12.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/2022666 78 63 17 31 29 26 63 23 99 48 49 140
2022/2023955 119 114 90 111 111 173 13 65 88 10 44 17
2023/2024779 21 50 17 55 199 46 52 39 43 59 83 115
2024/20251.928 86 170 53 185 148 103 93 187 116 223 201 363
2025/20264.275 430 301 419 318 440 224 485 152 354 308 584 260
Totale 12.607